Skip to main content
Skip to content
Case File
sd-10-EFTA01374179Dept. of JusticeOther

EFTA Document EFTA01374179

AGP LP 519 Alpha Group Capital Paul Barrett Alke° Capital Management FvkrSson A4enklpti. 20'1' Eton( New York, NY. 10017 Tet: 21271668010 New York I Song Kong- I Boston Dear Investor, Alkeon Growth Partners: Sept. 2017 2017 Alkeon Growth Strategy Since Inception (Cumulative) Alkeon Growth Strategy Since Inception (Annualized) Alkeon Growth Partners 0.47% 26.23% 1225.84%1 13.98%1 MSCI World 2.08% 14.24% 113.60% 3.92% MSCI AC World 1.77% 15.42% 113.66% 3.92% Alkeon

Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01374179
Pages
1
Persons
0
Integrity
Loading PDF viewer...

Summary

AGP LP 519 Alpha Group Capital Paul Barrett Alke° Capital Management FvkrSson A4enklpti. 20'1' Eton( New York, NY. 10017 Tet: 21271668010 New York I Song Kong- I Boston Dear Investor, Alkeon Growth Partners: Sept. 2017 2017 Alkeon Growth Strategy Since Inception (Cumulative) Alkeon Growth Strategy Since Inception (Annualized) Alkeon Growth Partners 0.47% 26.23% 1225.84%1 13.98%1 MSCI World 2.08% 14.24% 113.60% 3.92% MSCI AC World 1.77% 15.42% 113.66% 3.92% Alkeon

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
AGP LP 519 Alpha Group Capital Paul Barrett Alke° Capital Management FvkrSson A4enklpti. 20'1' Eton( New York, NY. 10017 Tet: 21271668010 New York I Song Kong- I Boston Dear Investor, Alkeon Growth Partners: Sept. 2017 2017 Alkeon Growth Strategy Since Inception (Cumulative) Alkeon Growth Strategy Since Inception (Annualized) Alkeon Growth Partners 0.47% 26.23% 1225.84%1 13.98%1 MSCI World 2.08% 14.24% 113.60% 3.92% MSCI AC World 1.77% 15.42% 113.66% 3.92% Alkeon Growth Partners Portfolio information (Approximate): Net Exposure (delta adjusted) 84.7% Gross Exposure 195% Number of Long Positions 98 Number of Short Positions 88 September offered positive results to global equities. Alkeon Growth Partners, LP returned 0.47%. Portfolio performance was positive in the US and Asia and negative in Europe. Our long positions had positive performance during the month while our short positions underperformed. We remain equally constructive on the current global opportunity set for both long and short investments, as we see significant sector-wide discrepancies between valuations and underlying fundamentals. As a result, we believe this is shaping up to be one of the best stock-picking environments since the 2000-01 technology bubble and have maintained a gross exposure at the high-end of our historical range. Furthermore, from a valuation perspective we consider many high quality growth sectors, such as technology and healthcare, to be undervalued and attractive relative to the market. There are three main drivers of portfolio performance so far this year, all of which we believe are likely to be persistent in years to come and favorable to our strategy, as we have detailed in our Q2 letter. One. outperformance of international stocks (for the first year since 2009), two, the beginning stages of valuation multiple renormalization of high quality growth stocks vs. low-growth defensive equity investments (i.e., high quality growth sectors, such as technology and healthcare, should ultimately trade at a premium to the market and especially to low-growth defensive sectors, such as utilities, consumer staples and REITs), and, three, strong fundamental performance ("beat-and-raise" quarterly results) by many high quality classic growth compounders. We believe all of these drivers are likely to persist beyond the short-term and continue to favor our strategy going forward (for reasons we detailed in our Q2 letter). In particular, we believe the fundamental performance of high quality classic growth compounders has the potential to not only persist but also strengthen in light of the upcoming wave of technological innovation (dubbed by many as 'the fourth industrial revolution"), which we believe can be broadly impactful and revolutionary in nature, similar to the internet wave of the CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) CONFIDENTIAL DB-SDNY-0068746 SDNY_GM_00214930 EFTA01374179

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.